Phase II Trial of Allovectin-7® for Metastatic Melanoma

Beth Israel Medical Center, New York

Hematology Oncology Associates of Baltimore, Baltimore

Duke University Medical Center, Durham

Comprehensive Blood and Cancer Center, Bakersfield

North Memorial Health Care, Robbinsdale

Mayo Clinic, Rochester

Oncology Specialists, S.C., Park Ridge

The Melanoma Center of Saint Louis, St Louis

Louisiana State University Medical Center, New Orleans

University of Arkansas Cancer Research Center, Little Rock

MD Anderson Cancer Center, Houston

University of Colorado Cancer Center, Denver

Arizona Cancer Center, Tucson

University of California, San Francisco, San Francisco

Cancer Care Alliance, Seattle

Dartmouth-Hitchcock Medical Center, Lebanon